EntryPoint Capital LLC Acquires 1,009 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS)

EntryPoint Capital LLC boosted its position in OrthoPediatrics Corp. (NASDAQ:KIDS) by 56.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,783 shares of the company’s stock after acquiring an additional 1,009 shares during the period. EntryPoint Capital LLC’s holdings in OrthoPediatrics were worth $81,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. CWM LLC lifted its holdings in shares of OrthoPediatrics by 16,283.3% in the fourth quarter. CWM LLC now owns 983 shares of the company’s stock valued at $32,000 after purchasing an additional 977 shares in the last quarter. International Assets Investment Management LLC increased its position in shares of OrthoPediatrics by 3,151.4% during the fourth quarter. International Assets Investment Management LLC now owns 1,203 shares of the company’s stock valued at $37,000 after acquiring an additional 1,166 shares during the last quarter. State Board of Administration of Florida Retirement System purchased a new stake in shares of OrthoPediatrics during the first quarter valued at approximately $178,000. Trust Point Inc. purchased a new stake in shares of OrthoPediatrics during the fourth quarter valued at approximately $216,000. Finally, Quantbot Technologies LP increased its position in shares of OrthoPediatrics by 180.8% during the first quarter. Quantbot Technologies LP now owns 7,091 shares of the company’s stock valued at $207,000 after acquiring an additional 4,566 shares during the last quarter. Institutional investors own 69.05% of the company’s stock.

Analyst Upgrades and Downgrades

KIDS has been the subject of a number of research analyst reports. Truist Financial decreased their price target on OrthoPediatrics from $38.00 to $35.00 and set a “hold” rating for the company in a research report on Tuesday, July 16th. Needham & Company LLC increased their price objective on OrthoPediatrics from $37.00 to $42.00 and gave the stock a “buy” rating in a report on Tuesday, May 7th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $50.00 target price on shares of OrthoPediatrics in a report on Tuesday, May 7th.

OrthoPediatrics Price Performance

NASDAQ:KIDS traded down $1.18 during trading hours on Friday, hitting $31.68. The stock had a trading volume of 78,516 shares, compared to its average volume of 164,033. The company has a 50 day simple moving average of $31.38 and a two-hundred day simple moving average of $29.69. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.45 and a quick ratio of 1.99. OrthoPediatrics Corp. has a one year low of $23.10 and a one year high of $43.17. The firm has a market capitalization of $754.93 million, a price-to-earnings ratio of -33.07 and a beta of 1.19.

OrthoPediatrics (NASDAQ:KIDS) last issued its earnings results on Monday, May 6th. The company reported ($0.30) EPS for the quarter, topping analysts’ consensus estimates of ($0.42) by $0.12. The company had revenue of $44.69 million for the quarter, compared to analysts’ expectations of $41.63 million. OrthoPediatrics had a negative net margin of 13.58% and a negative return on equity of 5.12%. Research analysts forecast that OrthoPediatrics Corp. will post -1.2 earnings per share for the current fiscal year.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.